Drug Profile
ADE 615
Alternative Names: ADE-615Latest Information Update: 07 Feb 2022
Price :
$50
*
At a glance
- Originator Adeptio Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for phase-I development in Schizophrenia in United Kingdom
- 27 Aug 2015 Investigation in Schizophrenia in United Kingdom (unspecified route)